Equity
Debts exceed assets in financial year 2025.
Debts exceed assets in financial year 2025.
The 2024 and 2025 financial years closed with a loss. 2025 was the heaviest.
Lower solvency than 95% of companies in research and development. Sector median 60.4% · 619 companies.
Negative equity caps the score at 59.
The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 6% of them on solvency, 10% on liquidity, 10% on profitability and 4% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 6,008 companies had the same profile as Future Proof has now. Each dot stands for 16 companies, two years later.
Another 0.8% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Future Proof itself is lower: 0.6% within 12 months. It rests on far more data about Future Proof than the profile alone.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,008 companies, not a prediction for Future Proof. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
The balance sheet total is too small for a liquidity verdict. Equity is negative.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 4 accounts on average 34 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| Future Proof Kasterlee | €4,667 | -€12,791 | -977.8% | - |
| Benebiose Ghent | €2,966 | €231 | -277.6% | - |
| BIOKEY Diepenbeek | €2,606 | -€16,079 | -8448.4% | - |
| Crop Mixtures with eXtended Technologies Tournai | €1,776 | -€6,063 | -372.3% | - |
| Organic Molecules Networks for the Industrial Sector Visé | €2,460 | -€643 | 33.1% | - |
| CELLTEST Woluwe-Saint-Lambert | €18,489 | -€26,024 | -416.0% | - |
| OTRO FOODS Seraing | €18,469 | -€28,746 | -33.4% | - |
These companies have the same main activity as Future Proof: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €1,780 and €18,500, founded between 2019 and 2023.
Future Proof files the micro format. That format states no turnover. The gross margin fell from -€4,734 in 2022 to -€12,791 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Turnover and EBIT margin are not published. The micro format does not require them.
Lower than 95% of 626 companies in 2024.
Higher than 8% of 607 companies in 2024.
Lower than 95% of 613 companies in 2024.
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Staff costs divided by the average number of full-time equivalents.
In 2025, nobody joined and 1 person left.
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
4,667 | 13,664 | 8,135 | 11,232 | |
29/58 |
4,667 | 13,664 | 8,135 | 11,232 | |
3 |
- | 0 | 3,877 | 3,304 | |
30/36 |
- | 0 | 3,877 | 3,304 | |
40/41 |
3,732 | 12,830 | 2,515 | 1,642 | |
40 |
3,138 | 10,554 | 1,538 | 1,001 | |
41 |
594 | 2,276 | 977 | 640 | |
54/58 |
852 | 835 | 1,627 | 6,286 | |
490/1 |
83 | 0 | 116 | - | |
| Balance sheet: equity and liabilities | |||||
10/49 |
4,667 | 13,664 | 8,135 | 11,232 | |
10/15 |
-45,632 | -19,039 | 470 | -7,586 | |
10/11 |
12,000 | 12,000 | 12,000 | 12,000 | |
14 |
-57,632 | -31,039 | -11,530 | -19,586 | |
17/49 |
50,298 | 32,703 | 7,664 | 18,818 | |
42/48 |
50,298 | 32,703 | 7,664 | 18,818 | |
44 |
9,419 | 8,704 | 238 | 945 | |
440/4 |
9,419 | 8,704 | 238 | 945 | |
45 |
655 | 3,461 | 0 | 3,276 | |
450/3 |
0 | 659 | - | - | |
454/9 |
655 | 2,803 | 0 | 3,276 | |
47/48 |
40,225 | 20,538 | 7,426 | 14,597 | |
| Income statement | |||||
9900 |
-12,791 | 116 | -6,549 | -4,734 | |
62 |
7,300 | 18,893 | 2,794 | 12,700 | |
630 |
- | - | 0 | 900 | |
640/8 |
6,437 | 455 | 690 | 1,203 | |
9901 |
-26,528 | -19,232 | -10,033 | -19,537 | |
75/76B |
130 | 6 | 18,312 | - | |
75 |
130 | 6 | - | - | |
76B |
- | 0 | 18,312 | - | |
65/66B |
195 | 283 | 222 | 49 | |
65 |
195 | 283 | 222 | 49 | |
9903 |
-26,593 | -19,509 | 8,057 | -19,586 | |
9904 |
-26,593 | -19,509 | 8,057 | -19,586 | |
9905 |
-26,593 | -19,509 | 8,057 | -19,586 | |
| Appropriation of the result | |||||
9906 |
-57,632 | -31,039 | -11,530 | -19,586 | |
14P |
-31,039 | -11,530 | -19,586 | - | |
| Social balance sheet | |||||
9087 |
0.1 | 0.9 | 1 | 0.4 | |
Hours worked1013 |
216 | 978 | 300 | 756 | |
| Document | |||||
The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 21-07-2026.
| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 2 | €0 | €20,000 |
| 2024 | 1 | €40,000 | €0 |
| 2023 | 1 | €435 | €435 |
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| - | - | -10,033 | -18,637 | ||
| - | - | 8,057 | -18,686 | ||
| - | - | 0 | 900 | ||
| 18 | -792 | -4,659 | - | ||
| -45,632 | -19,039 | 470 | -7,586 | ||
| - | -139.3% | 5.8% | -67.5% | ||
| - | 0.42 | 1.06 | 0.60 | ||
| - | 0.42 | 0.56 | 0.42 | ||
| - | -142.8% | 99.0% | -174.4% | ||
| - | - | -45.16 | -381.76 |
The ratios are withheld because a balance sheet total of €4,667 is too small for a meaningful ratio.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 |
|---|---|---|---|---|
| Employees at the balance-sheet date | 0 | 1 | - | 1 |
| full-time | 0 | 1 | - | 1 |
| part-time | 0 | 0 | - | 0 |
| in full-time equivalents | 0 | 1 | - | 1 |
| 0.1 | 0.6 | 0.2 | - | |
| On a permanent contract | 0 | 1 | - | 1 |
| Joined | 0 | 4 | 0 | 2 |
| Left | 1 | 3 | 1 | 1 |
| Training hours | 0 | 0 | - | - |
Source: social balance sheet in the 2022 to 2025 annual accounts
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Intangible fixed assets | - | - | - | €900 |
| - | - | €0 | €900 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is a loss of €26,528, larger than the loss of €19,232 in 2024. It is the lowest result since 2022.
Equity is negative. Debt (€50,298) exceeds the balance-sheet total (€4,667).
Future Proof has no parent and no holdings in its annual accounts. Future Proof shares no director with another company.
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
Future Proof was incorporated on 16 July 2021 as a private limited company by FUTURE PROOF GMBH and two natural persons, with a starting capital of €12,000.12 The registered office moved to Lichtaart in 2021 and to Kasterlee in 2023.34 The board currently has 2 members.5 Total assets fell from €11,232 in 2022 to €4,667 in 2025 and headcount from 0.4 to 0.1 full-time equivalents.6
| Establishment | Since | Unit number |
|---|---|---|
| Duifhuis 6 registered office 2460 Kasterlee | 16-07-2021 | 2.319.487.061 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 13018F0401/00Y000 | 399 m² | 1 · 90 m² | 3.2 m |
If something looks wrong or is missing, please tell us.